UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Benefits of Decreased Mortality Risk from Reductions in Primary Mobile Source Fine Particulate Matter: A Limited Data Approach for Urban Areas Worldwide

Risk analysis, 2016-09, Vol.36 (9), p.1783-1802

2016

Volltextzugriff (PDF)

A method to screen U.S. environmental biomonitoring data for race/ethnicity and income-related disparity

Environmental health, 2013-12, Vol.12 (1), p.114-114, Article 114

2013

Volltextzugriff (PDF)

Spatial patterns of mobile source particulate matter emissions-to-exposure relationships across the United States

Atmospheric environment (1994), 2007-02, Vol.41 (5), p.1011-1025

2007

Volltextzugriff (PDF)

An approach to estimating the environmental burden of cancer from known and probable carcinogens: application to Ontario, Canada

BMC public health, 2020-06, Vol.20 (1), p.1-13, Article 1017

2020

Volltextzugriff (PDF)

Evaluating Efficiency-Equality Tradeoffs for Mobile Source Control Strategies in an Urban Area

Risk analysis, 2009-01, Vol.29 (1), p.34-47

2009

Volltextzugriff (PDF)

Factors Influencing Mobile Source Particulate Matter Emissions-to-Exposure Relationships in the Boston Urban Area

Environmental science & technology, 2007-11, Vol.41 (22), p.7675-7682

2007

Volltextzugriff (PDF)

Global Climate Implications for Homelessness: A Scoping Review

Journal of urban health, 2021-06, Vol.98 (3), p.385-393

2021

Volltextzugriff (PDF)

The Importance of Population Susceptibility for Air Pollution Risk Assessment: A Case Study of Power Plants near Washington, DC

Environmental health perspectives, 2002-12, Vol.110 (12), p.1253-1260

2002

Volltextzugriff (PDF)

Estimated burden of disease from arsenic in drinking water supplied by domestic wells in the United States

Journal of water and health, 2019-10, Vol.17 (5), p.801-812

2019

Volltextzugriff (PDF)

Oral tablet vaccination against SARS-CoV-2 spike boosts cross-reactive serum and mucosal neutralizing antibodies following mRNA vaccination: a phase 2 clinical trial

The Journal of immunology (1950), 2023-05, Vol.210 (1_Supplement), p.246-246.09

2023

Volltextzugriff (PDF)

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

The Lancet (British edition), 2017-04, Vol.389 (10077), p.1399-1409

2017

Volltextzugriff (PDF)

Correction to: Global Climate Implications for Homelessness: A Scoping Review

Journal of urban health, 2021-02, Vol.98 (1), p.158-158

2021

Volltextzugriff (PDF)

Estimates of healthcare utilisation and deaths from waterborne pathogen exposure in Ontario, Canada

Epidemiology and infection, 2020-03, Vol.148, p.e70, Article e70

2020

Volltextzugriff (PDF)

Estimated Annual Deaths, Hospitalizations, and Emergency Department and Physician Office Visits from Foodborne Illness in Ontario

Foodborne pathogens and disease, 2019-03, Vol.16 (3), p.173-179

2019

Volltextzugriff (PDF)

Optimization of Urban Transportation Fleet PM2.5 Emission Reduction Strategies Using an Intake Fraction Framework

Epidemiology (Cambridge, Mass.), 2006-11, Vol.17 (Suppl), p.S29-S30

Greco, Susan

2006

Volltextzugriff (PDF)

Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Three Years' Experience

Clinical journal of the American Society of Nephrology, 2011-10, Vol.6 (10), p.2499-2507

2011

Volltextzugriff (PDF)

Ragaglitazar Improves Glycemic Control and Lipid Profile in Type 2 Diabetic Subjects

Diabetes care, 2004-06, Vol.27 (6), p.1324-1329

2004

Volltextzugriff (PDF)

Public Health Ontario's Environmental Burden of Disease Project

Environmental health perspectives. Supplements, 2018-09, Vol.2018 (1)

2018

Volltextzugriff (PDF)

Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic Subjects: A 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm

Diabetes care, 2004-06, Vol.27 (6), p.1324-1329

2004

Volltextzugriff (PDF)

Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial

Diabetes, obesity & metabolism, 2010-04, Vol.12 (4), p.348-355

2010

Volltextzugriff (PDF)

Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone

Diabetes research and clinical practice, 2004-02, Vol.63 (2), p.127-134

2004

Volltextzugriff (PDF)

Private companies adopt SOX

The National Law Journal, 2005-08, Vol.27 (51), p.8

Greco, Susan

2005

Volltextzugriff (PDF)

He can close but how is his interpersonal sensitivity? Testing sales recruits

Inc. (Boston, Mass.), 2009-03, Vol.31 (2), p.96

Greco, Susan

2009

Volltextzugriff (PDF)

He can close, but how is his interpersonal sensitivity?

Inc. (Boston, Mass.), 2009-03, Vol.31 (2), p.96

Greco, Susan

2009

Volltextzugriff (PDF)

Fighting the sales force blues: how to keep reps motivated when they miss their numbers

Inc. (Boston, Mass.), 2008-09, Vol.30 (9), p.47

Greco, Susan

2008

Volltextzugriff (PDF)

1 – 25 von 510

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(478)

Publikationsform

Sprache

Englisch
(510)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Benefits of Decreased Mortality Risk from Reductions in Primary Mobile Source Fine Particulate Matter: A Limited Data Approach for Urban Areas Worldwide

A method to screen U.S. environmental biomonitoring data for race/ethnicity and income-related disparity

Spatial patterns of mobile source particulate matter emissions-to-exposure relationships across the United States

An approach to estimating the environmental burden of cancer from known and probable carcinogens: application to Ontario, Canada

Evaluating Efficiency-Equality Tradeoffs for Mobile Source Control Strategies in an Urban Area

Factors Influencing Mobile Source Particulate Matter Emissions-to-Exposure Relationships in the Boston Urban Area

Global Climate Implications for Homelessness: A Scoping Review

The Importance of Population Susceptibility for Air Pollution Risk Assessment: A Case Study of Power Plants near Washington, DC

Estimated burden of disease from arsenic in drinking water supplied by domestic wells in the United States

Oral tablet vaccination against SARS-CoV-2 spike boosts cross-reactive serum and mucosal neutralizing antibodies following mRNA vaccination: a phase 2 clinical trial

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Correction to: Global Climate Implications for Homelessness: A Scoping Review

Estimates of healthcare utilisation and deaths from waterborne pathogen exposure in Ontario, Canada

Estimated Annual Deaths, Hospitalizations, and Emergency Department and Physician Office Visits from Foodborne Illness in Ontario

Optimization of Urban Transportation Fleet PM2.5 Emission Reduction Strategies Using an Intake Fraction Framework

Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Three Years' Experience

Ragaglitazar Improves Glycemic Control and Lipid Profile in Type 2 Diabetic Subjects

Public Health Ontario's Environmental Burden of Disease Project

Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic Subjects: A 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm

Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial

Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone

Private companies adopt SOX

He can close but how is his interpersonal sensitivity? Testing sales recruits

He can close, but how is his interpersonal sensitivity?

Fighting the sales force blues: how to keep reps motivated when they miss their numbers

Aktive Filter

Suchergebnisse filtern